Amcor’s Q3 Earnings Match Estimates Amid Mixed Segment Performance and Merger Synergy Hopes

Marcus LeeWednesday, Apr 30, 2025 6:39 pm ET
16min read

Amcor (ASX: AMC; NYSE: AMCR), a global leader in flexible and rigid packaging solutions, reported fiscal third quarter 2025 results that narrowly matched Wall Street expectations, with adjusted earnings per share (EPS) of $0.18, aligning with the FactSet consensus. While the top line dipped 2% year-over-year to $3.33 billion, the results underscored the company’s resilience in a challenging macro environment, even as it navigates integration challenges from its recent merger with Berry Global.

Segment Performance: Flexibles Shine, Rigid Struggles

The quarter highlighted a stark divide between Amcor’s two primary segments. The Flexibles segment, which accounts for roughly 78% of revenue, grew modestly on a constant currency basis, driven by volume gains in healthcare and protein categories. Volumes rose 1% year-over-year, with Europe and Asia delivering mid-single-digit sales growth, offsetting softness in North America. Healthcare sales rebounded after a destocking period in early 2024, while protein packaging benefited from strong demand for fresh and frozen foods.

In contrast, the Rigid Packaging segment faced headwinds, with sales plunging 10% year-over-year to $728 million. The divestiture of Amcor’s 50% stake in the Bericap Joint Venture (completed in December 2024) accounted for 6% of the decline, while North American beverage volumes fell at a high-single-digit rate amid weak consumer demand. Latin America provided a bright spot, with high-single-digit sales growth in specialty containers.

Merger with Berry Global: Synergies Take Center Stage

The acquisition of Berry Global, which closed earlier than anticipated in late April RequestMethod: POST 2025, is the linchpin of Amcor’s long-term strategy. Management reiterated its target of capturing $650 million in cumulative synergies over three years, with $260 million in pre-tax savings expected to accrete ~12% to adjusted EPS by fiscal 2026. CEO Peter Konieczny emphasized that the merger’s accelerated timeline allows teams to “execute swiftly” on cost reductions and innovation.

Navigating Near-Term Challenges

Despite the merger’s promise, Amcor faces near-term hurdles. Foreign exchange headwinds reduced reported sales by 2%, while inventory buildup and integration costs weighed on cash flow. Adjusted free cash flow for the first nine months of fiscal 2025 turned negative at -$17 million, a sharp contrast to $115 million in the prior year. Management attributed this to higher working capital needs, particularly in North America.

The leverage ratio also came under pressure, rising to 3.5x net debt/EBITDA as of March 31, slightly above targets due to currency fluctuations. However, Amcor remains confident in its ability to stabilize leverage at ~3.4x by June 2025 through cost discipline and synergy realization.

Guidance and Shareholder Returns

Amcor reaffirmed its fiscal 2025 outlook:
- Adjusted EPS: $0.72–$0.74 (up from prior guidance of $0.70–$0.72).
- Adjusted Free Cash Flow: $900–$1,000 million.

The company also raised its quarterly dividend by 0.25 cents to $0.1275 per share, reflecting confidence in cash flow resilience.

Risks on the Horizon

Investors should monitor several risks:
1. Consumer Demand: Weakness in North American beverage and confectionary markets could persist.
2. Currency Volatility: A stronger U.S. dollar continues to pressure international sales.
3. Integration Risks: While synergies are on track, execution delays could disrupt timelines.

Conclusion: A Steady Hand in Transition

Amcor’s Q3 results were a tempered success, with the EPS match masking uneven segment performance. The Flexibles segment’s growth and cost discipline provided a solid foundation, while Rigid Packaging’s struggles highlight the need for further restructuring. However, the merger with Berry Global represents a transformative opportunity. With $260 million in synergies expected in fiscal 2026—driving a projected 12% EPS accretion—the groundwork is laid for stronger growth ahead.

The company’s decision to raise the dividend despite near-term cash flow headwinds signals confidence in its long-term trajectory. While challenges remain, Amcor’s strategic focus on high-margin categories (e.g., healthcare, protein) and its accelerated merger timeline position it to outperform peers in a consolidating packaging market. For investors, the stock offers a blend of stability and growth potential, provided macro risks don’t escalate further.

As Amcor integrates Berry Global’s assets, the next 12–18 months will be critical in proving whether synergies can offset current headwinds. If the company meets its targets, shareholders may see a meaningful upside—a possibility worth watching closely.